Influence of diet on visceral adipose remodeling in NONcNZO10 mice with polygenic susceptibility for type 2 diabetes

Obesity

Volumn 20, Issue 10, 2012, Pages 2142-2146

  Adi, Nikhil C ^a   Adi, Jennipher N ^a   Cesar, Liliana ^a   Agatston, Arthur S ^b   Kurlansky, Paul ^c   Webster, Keith A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Agatston Research Institute   (United States)

^c Florida Heart Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN K; CATHEPSIN X; FATTY ACID BINDING PROTEIN 4; FISH OIL; GELATINASE A; GELATINASE B; GLUCOSE; INSULIN; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 25; NEUTROPHIL COLLAGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VON WILLEBRAND FACTOR;

ANGIOGENIC GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DOWN REGULATION; ENZYME INDUCTION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; MALE; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN DIET; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED CBA; MICROARRAY ANALYSIS; OBESITY; PPAR GAMMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR; WEIGHT GAIN;

MUS;

EID: 84866733310     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.167     Document Type: Article

References (19)

1. Reifsnyder PC, Leiter EH. Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes 2002;51:825-832.
2. Cho RY, Kim JH, Park YS, et al. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZ010/LtJ males, a new mouse model of type 2 diabetes. Am J Physiol Endocrinol Metab 2007;293:E327-E336.
3. Leiter EH, Reifsnyder PC, Xiao Q, Mistry J. Adipokine and insulin profiles distinguish diabetogenic and non-diabetogenic obesities in mice. Obesity (Silver Spring) 2007;15:1961-1968.
4. Herberg L. Insulin resistance in abdominal and subcutaneous obesity: comparison of C57BL/6J-ob/ob with New Zealand obese mice. In: Shafrir E, Renold A, (eds). Frontiers in Diabetes Research: Lessons from Animal Diabetes II. John Libbey & Company Ltd.: London, UK, 1988, pp 367-373.
5. Zhou J, Martin RJ, Tulley RT et al. Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J Agric Food Chem 2009;57:8844-8851.
6. Qiu J, Cheng R, Zhou XY et al. Gene expression profiles of adipose tissue of high-fat diet-induced obese rats by cDNA microarrays. Mol Biol Rep 2010;37:3691-3695.
7. Huber J, Löffler M, Bilban M et al. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 2007;31:1004-1013.
8. Meissburger B, Stachorski L, Röder E, Rudofsky G, Wolfrum C. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 2011;54:1468-1479.
9. Minematsu T, Huang L, Ibuki A et al. Altered expression of matrix metalloproteinases and their tissue inhibitors in matured rat adipocytes in vitro. Biol Res Nurs 2012;14:242-249.
10. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002;51:1093-1101.
11. Chavey C, Mari B, Monthouel MN et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003;278:11888-11896.
12. Van Hul M, Lijnen HR. A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 2008;6:1198-1206.
13. Derosa G, Ferrari I, D'Angelo A et al. Matrix metalloproteinase-2 and-9 levels in obese patients. Endothelium 2008;15:219-224.
14. Daquinag AC, Zhang Y, Kolonin MG. Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci 2011;32:300-307.
15. Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care 2010;13:371-376.
16. Wilson A, Shehadeh LA, Yu H, Webster KA. Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 2010;11:2 29.
17. Chopra I, Li HF, Wang H, Webster KA. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 2012;55:783-794.
18. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P. Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 2009;458:1103-1114.
19. Kubota Y, Terauchi H, Miki K, et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609.